Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Peter Singleton who wrote (3713)	2/2/1998 9:15:00 AM
From: sam	Read Replies (1) \| Respond to of 6136

newsalert.com

To: Peter Singleton who wrote (3713)	2/3/1998 11:50:00 PM
From: Timothy Kross	Respond to of 6136

Peter: There is an article in Internal Medicine News that is interesting. Dr. Christopher Filippi, a neuroradiologist from Albert Einstein College of Medicine, reported that protease inhibitors reverse AIDS related dementia. This is an unexpected finding. MRI scans showed regression of white matter disease in patients on PIs with AIDS related encephalopathy. Sixteen patients at Yale New Haven Hospital were studied, nine on PIs (IND, SAQ, and RTV) and seven controls. Those treated with PIs showed both clinical neurocognitive improvement and improved or stabilized MRI scans showing regression of white matter disease. The seven controls showed progression of disease and were on various other non PI drugs. The thinking had been that the CNS might be a reservoir of infection that would show disease progression because of concern about PIs being ineffective in the CNS. This is an optimistic report. Best regards, Tim